Keflex and Pregabalin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Keflex (cephalexin) and Pregabalin (pregabalin). Common drug interactions include oedema among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Keflex and Pregabalin. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Keflex?

Keflex has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 15,844 Keflex users. Check the latest studies of Keflex.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.



On Jul, 12, 2026

59 people who take Keflex and Pregabalin together, and have interactions are studied.

Keflex and Pregabalin drug interactions.

What are the common drug interactions of Keflex and Pregabalin, by gender? *:

female:

  1. Oedema (fluid collection in tissue)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Peripheral swelling
  4. Rash
  5. Swelling
  6. Abdominal distension
  7. Alveolar osteitis (complication of wound healing following extraction of a tooth)
  8. Anaemia (lack of blood)
  9. Animal scratch
  10. Balance disorder

male:

  1. Asthenia (weakness)
  2. Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)
  3. Presyncope
  4. Thrombosis (formation of a blood clot inside a blood vessel)
  5. Central nervous system haemorrhage (bleeding in brain and surrounding)
  6. Spinal column stenosis (narrowing of spinal column)
  7. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  8. Adverse drug reaction
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)

What are the common drug interactions of Keflex and Pregabalin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  2. Pneumonia
  3. Alanine aminotransferase increased
  4. Burning sensation
  5. Cataract subcapsular (cataracts that affect the back of the lens)
  6. Cystoid macular oedema (fluid accumulation after cataract surgery)
  7. Diabetes mellitus inadequate control
  8. Diabetic retinal oedema (excessive build-up of fluid in the retina due to diabetes)
  9. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  10. Dizziness

50-59:

  1. Calcium ionised increased
  2. Candiduria (candida in urine)
  3. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  4. Depression
  5. Graft thrombosis (clotting at graft)
  6. Haemorrhage (bleeding)
  7. Heparin-induced thrombocytopenia
  8. Hypotension (abnormally low blood pressure)
  9. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  10. Memory impairment

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Nausea (feeling of having an urge to vomit)
  3. Arthralgia (joint pain)
  4. Back pain
  5. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  6. Chills (felling of cold)
  7. Decreased appetite
  8. Ear pain
  9. Erythema (redness of the skin)
  10. Fall

What are the existing conditions these people have? *

  1. Pain: 13 people, 22.03%
  2. Stress And Anxiety: 7 people, 11.86%
  3. High Blood Cholesterol: 7 people, 11.86%
  4. Multiple Myeloma (cancer of the plasma cells): 7 people, 11.86%
  5. Insomnia (sleeplessness): 7 people, 11.86%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 10.17%
  7. Asthma: 6 people, 10.17%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 10.17%
  9. Peripheral Sensory Neuropathy (damage to one or more of your peripheral nerves): 5 people, 8.47%
  10. Neuropathy Peripheral (surface nerve damage): 5 people, 8.47%

* Approximation only. Some reports may have incomplete information.

Do you take Keflex and Pregabalin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Keflex and Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Keflex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keflex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pregabalin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cephalexin and pregabalin (the active ingredients of Keflex and Pregabalin, respectively), and Keflex and Pregabalin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: